Great article from ‘The Economist’: Seattle and Silicon Valley are joined at the hip
The San Diego Monthly Employment Report (February 2017 to March 2017) shows increases in the civilian labor force and employment, and no change in the unemployment rate.
Sam Zelll always has an interesting take on commercial real estate markets, and can often be a contrarian, I haven’t done the math, but it seems he is right more often than he is wrong.
Here are San Diego’s top 10 first-quarter deals, based on PitchBook data from the Venture Monitor report.
|Vividion Therapeutics||$50 million||BioPharma|
|F1 Oncology||$44 million||Anti-cancer|
|Biological Dynamics||$28.9 million||Anti-cancer|
|Dauntless Pharmaceuticals||$25 million||BioPharma|
|Jecure Therapeutics||$20 million||BioPharma|
|Oncternal Therapeutics||$18.4 million||Anti-cancer|
|Genoa Pharmaceuticals||$16.6 million||BioPharma|
|Avidity Biosciences||$16 million||BioPharma|
|Echo Laboratories||$12.9 million||Healthtech|
Will cannabis ever be removed from the Schedule 1 Drug List?
The San Diego Monthly Employment Report (January 2017 to February 2017) shows an increase in employment and decreases in the civilian unemployment rate and labor force.